A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer
Ilya Tsimafeyeu(Russian Cancer Research Center NN Blokhin), Galina Statsenko(Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center"), Л. Ю. Владимирова(Rostov Research Institute of Oncology), Natalia Besova, Elena Artamonova, Г. А. Раскин(St.Petersburg V.M.Bekhterev Psychoneurological Research Institute), I. A. Rykov(Russian Academy of Sciences), Anastasia Mochalova(Clinical Hospital No. 8), Igor Utyashev, Svetlana Gorbacheva, V. I. Kazey, Evgenia Gavrilova, Nadezhda Dragun, Vladimir Moiseyenko(State Budget Institution of Health St. Petersburg Clinical Research Center Specialized Types of Medical Care), Sergei Tjulandin
Cited by 8
Abstract
Related Papers
No related papers found
Powered by citation graph analysis